According to the latest report by IMARC Group “Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global inhalation anesthesia market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2027, exhibiting a growth rate (CAGR) of 3.8% during 2022-2027.
Inhalation anesthesia refers to the medication that is induced to maintain the general anesthesia and sedation level in the body during surgery. It does not accumulate in the body and helps prevent excessive dosage while promoting the normal functioning of the patient. Inhalation anesthetic agents with low pungency and non-irritant odor are widely used in hospitals and other ambulatory healthcare centers for patients with asthma or sensitive air passages.
Request for a free sample copy of this report: https://www.imarcgroup.com/inhalation-anesthesia-market/requestsample
Market Trends:
The global inhalation anesthesia market is primarily driven by the growing aging population, which is more susceptible to cardiovascular, neurological, respiratory and degenerative disorders. Besides this, the increasing number of surgical procedures has also led to an escalated demand for inhalation anesthesia, which has a lower risk of delirium and is cost-effective than intravenous anesthesia(IVA). Furthermore, the development of anesthesia recycling systems for extracting anesthetic compounds from hospital vents and operating rooms is also contributing to the market growth. Some of the other factors, such as the introduction of variants with enhanced compatibility and minimal side-effects, improvements in the healthcare sector and extensive research and development (R&D) activities, provide positive growth to the market.
Breakup by Product:
- Desflurane
- Sevoflurane
- Isoflurane
- Others
Breakup by Application:
- Induction
- Maintenance
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbvie Inc.
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Halocarbon Products Corporation
- Hikma Pharmaceuticals PLC
- Lunan Pharmaceutical Group Co. Ltd
- Merck KGaA
- Piramal Enterprises Ltd.
- Troikaa Pharmaceuticals Ltd.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/inhalation-anesthesia-market
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
